Crossmark

Effects of SLC22A2 808G>T polymorphism and bosutinib concentrations on serum creatinine in patients with chronic myeloid leukemia receiving bosutinib therapy

Crossref DOI link: https://doi.org/10.1038/s41598-021-85757-7

Published Online: 2021-03-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abumiya, Maiko

Takahashi, Naoto

Takahashi, Saori

Yoshioka, Tomoko

Kameoka, Yoshihiro

Miura, Masatomo
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (20K07150)
License Information

Text and Data Mining valid from 2021-03-18

Version of Record valid from 2021-03-18
More Information

Article History

Received: 20 October 2020

Accepted: 5 March 2021

First Online: 18 March 2021

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below